Cantor analyst Irina Rivkind came out with a research note on Synergy Pharmaceuticals Inc (NASDAQ:SGYP), after the company released its fourth-quarter results, posting a net loss of $30.6M and …
In a research report released Tuesday, Cantor analyst Irina Rivkind reiterated a Buy rating on Eagle Pharmaceuticals Inc (NASDAQ:EGRX) with a $37 price target, following the …
In a research report published Monday, Cantor analyst Irina Rivkind maintained a Buy rating on Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and raised the price target to $214, …
Cantor analyst Irina Rivkind was out today pounding the table on Jazz Pharmaceuticals (NASDAQ:JAZZ) Monday, reiterating a Hold rating and a price target of $195. …
In a research report sent to investors today, Cantor Fitzgerald analyst Irina Rivkind maintained a Hold rating on Ligand Pharmaceuticals (NASDAQ:LGND) with a $49 price target, as the company updated its 3Q:14 …
In a research report sent to investors today, Cantor Fitzgerald analyst Irina Rivkind reiterated a Buy rating on Synergy Pharmaceuticals (NASDAQ:SGYP) with a $11 price target, as the …
In a research report published today, Cantor Fitzgerald analyst Irina Rivkind reiterated her Buy rating on Salix Pharma (NASDAQ:SLXP) and increased her price …
In a research note published this morning, Cantor Fitzgerald analyst Irina Rivkind reiterated a Buy rating on Evoke Pharma (NASDAQ:EVOK) with a $20 …
In a research note published today, Cantor Fitzgerald analyst Irina Rivkind maintained a Buy on Phibro Animal Health (NASDAQ:PAHC) with a $27 price target, …
In a research note released this morning, Cantor Fitzgerald analyst Irina Rivkind reiterated a Sell rating on Endo Health Solutions (NASDAQ:ENDP) but increased …
